Search results
•NICE guideline (DG23) PlGF-based testing to help diagnose suspected pre-eclampsia (Triage PlGF test, Elecsys immunoassay sFlt-1/PlGF ratio, DELFIA Xpress PlGF 1-2-3 test, and BRAHMS sFlt-1 Kryptor/BRAHMS PlGF plus Kryptor PE ratio).
- NICE Guidelines - Action on Pre-eclampsia
Guideline . Covers diagnosing and managing hypertension...
- NICE Guidelines - Action on Pre-eclampsia
25 cze 2019 · Recommendations for research. As part of the 2019 update, the guideline committee made 6 research recommendations on the management of pregnancy with chronic hypertension, pre-eclampsia, fetal monitoring, the use of antihypertensives in breastfeeding and advice and follow-up.
25 cze 2019 · This guideline covers diagnosing and managing hypertension (high blood pressure), including pre-eclampsia, during pregnancy, labour and birth. It also includes advice for women with hypertension who wish to conceive and women who have had a pregnancy complicated by hypertension.
• Before 37 weeks: consider planned early birth in women with severe pre-eclampsia. • After 37 weeks: initiate birth within 24 to 48 hours. • If planned early birth offer antenatal corticosteroids and magnesium sulfate if indicated, in line with the NICE guideline on preterm labour and birth.
Women who develop severe pre-eclampsia and eclampsia. The guidance encompasses the principles within the NICE clinical guidance (NG133) hypertension in pregnancy: diagnosis and management, and NICE Quality Standard number 35 hypertension in pregnancy.
Guideline . Covers diagnosing and managing hypertension (high blood pressure), including preeclampsia, during pregnancy, labour and birth. Includes advice for women with hypertension who wish to conceive and women who have had a pregnancy complicated by hypertension.
Pre-eclampsia is a multi-system disorder unique to human pregnancy characterised by hypertension and involvement of one or more other organ systems and/or the fetus. Raised blood pressure is commonly, but not always, the first manifestation. Proteinuria is the most commonly recognised additional feature after hypertension but should no longer ...
